Variable | Pharmacist counseled n = 100 | Standard of care n = 100 | P-value |
---|---|---|---|
Learner specifieda | 97 | 34 | < 0.001 |
Patient | 82 | 34 | < 0.001 |
Family member | 77 | 20 | < 0.001 |
Other | 1 | 0 | 0.014 |
Counseling method specifiedb | 97 | 33 | < 0.001 |
Verbal education | 97 | 33 | < 0.001 |
Written educational material | 95 | 0 | < 0.001 |
Language of written education material | |||
Arabic | 18 | 2 | < 0.001 |
English | 40 | 10 | < 0.001 |
Not documented | 42 | 88 | < 0.001 |
Response of patient documented | 100 | 33 | < 0.001 |
Patient verbalized understanding | 100 | 33 | < 0.001 |
Patient needs reinforcement; re-evaluate education at another time | 2 | 1 | 0.014 |
Instructions declined | 1 | 0 | 0.014 |
Documented barriers to learning | 65 | 33 | < 0.001 |
Age-related | 6 | 0 | < 0.001 |
Cognitive | 2 | 0 | 0.007 |
Emotional | 1 | 0 | 0.014 |
Hearing | 1 | 0 | 0.014 |
No Barrier | 84 | 33 | < 0.001 |
Elements of patient education | |||
Rationale for therapy | 92 | 5 | < 0.001 |
Dosing | 91 | 5 | < 0.001 |
Monitoring | 91 | 5 | < 0.001 |
INR (for patients receiving Vitamin K antagonist) | 33 | 2 | < 0.001 |
Duration of therapy | 82 | 5 | < 0.001 |
Administration | 92 | 5 | < 0.001 |
Importance of compliance | 94 | 5 | < 0.001 |
Missed dose | 91 | 5 | < 0.001 |
Storage | 88 | 5 | < 0.001 |
Drug-drug interaction | 88 | 5 | < 0.001 |
Drug-food interaction | 88 | 5 | < 0.001 |
Signs and symptoms of bleeding | 90 | 5 | < 0.001 |
Reversal agent | 32 | 2 | < 0.001 |
Precautions | 93 | 5 | < 0.001 |
Patient communication with healthcare provider | 41 | 1 | < 0.001 |
Discharge medications documented in chart | 94 | 84 | 0.024 |
Informed patient about next appointment date with physician | 31 | 52 | < 0.001 |
Time of next appointment (mean in days, +/− SD) | 15.00 +/− 12.49 | 17.67 +/− 14.53 | 0.341 |